Pat Whitworth ex-Chairman of the American Society of Breast Surgeons and Committee member of TME presents Digistain as a “game changer with its highly disruptive technology” with its ability to streamline throughout in evaluating patient risk for hormone-positive breast cancer.
Digistain Presents Key Research Findings at the San Antonio Breast Cancer Symposium 2024
Last week, we were proud to present two abstracts at the San Antonio Breast Cancer Symposium 2024. The first abstract showcased head-to-head data from Charing
